Lippoldt Darin bought NBIX
January 22, 2024 · Form 4 insider transaction
Lippoldt Darin bought 10,000 shares of Neurocrine Biosciences, Inc. at $79.02 per share, a transaction worth $790.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$79.02
Total value
$790.2K
InsiderLippoldt Darin
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 22, 2024
Filing dateJanuary 24, 2024
Shares owned after45,882
OwnershipDirect
10b5-1 planNo
AmendedNo